Species: Human, Mouse, Rat, Non-Human Primate, Other
Product Overview
SU5402 is a potent multi-targeted receptor tyrosine kinase inhibitor with IC50 of 20 nM, 30 nM, and 510 nM for VEGFR2, FGFR1, and PDGF-Rβ, respectively. Additionally, SU5402 has been observed to inhibit IL-1 beta-induced MAPK activity.